PAEAN develops revolutionary first-in-class mitochondrial medicinal products.
Kyuboem Han, PhD
Dr. Han is the current CEO/President of PAEAN Biotech. Dr. Han has more than 35 years of experience in the development and commercialization of biopharmaceuticals, biomaterials, hyaluronate-related medicinal products and medical devices, cell therapy products, and various bio-related products, including cosmetics. Before founding PAEAN Biotechnology Inc. in 2013, Dr. Han was a principal research scientist at Lucky Biotech (USA) and LG Life Sciences (Korea) for 15 years.
He served as President of the Bio Development Division at CHA Biotech and as President at Hanson Biotech. His works and dedication earned him several awards from LG Group and the Korean Government. Dr. Kim received his Ph.D. from the University of California, Irvine in 1994.
CEO / President
Chun-Hyung Kim, PhD
Dr. Kim majored in Molecular Neurobiology from the University of Tennessee where he obtained his Ph.D. Dr. Kim was a principal research scientist and team leader for more than 10 years at LG Life Science in Korea. In 2004, he joined the Molecular Neurobiology Laboratory at McLean Hospital/Harvard Medical School. Dr. Kim has issued 11 patents besides 53 patents as co-inventors and published more than 50 research papers. Currently, Dr. Kim has served as CSO and Senior Vice President at PAEAN since 2016.
CSO / Senior VP
Sang-Min Lim, PhD
Dr. Lim received his Ph.D. from Inha University specialized in cell therapy. He has vast experience in anti-cancer drugs and vaccines. Prior to joining PAEAN, Dr. Lim was in Boryung Pharmaceutical Co., Ltd where he developed dendritic cell anti-cancer vaccine, chickenpox vaccine, etc. Dr. Lim has served as Head of Mitochondria Development Division and Vice President at PAEAN since 2019.
Head of Division / VP
Kyu Shik Hahn, MBA
Kyu has served as Chief Financial Officer at PAEAN since June 2020. He has extensive global experience in finance, marketing, and corporate development in a range of financial services. Prior to joining PAEAN, he was in Citibank Korea and Singapore and in OCBC Bank Singapore. Kyu graduated from the University of Chicago where he obtained his MBA. Also, he holds BA/MA from Yonsei University
CFO / VP
Hahnsun Jung, PhD
Dr. Jung has more than 25 years of industrial experience in the development and commercialization of biopharmaceuticals, chemical new drugs, and medical device products. Prior to joining PAEAN, Dr. Jung was in the research institute of Boryung Pharmaceutical. Co., Ltd. Dr. Jung received her Ph.D. from Inha University in 2000. She joined PAEAN in 2019.
Director / VP
Dr. Cornelius Sobel
Cornelius Sobel has over 25 years of experience in the pharmaceutical industry. He gained extensive expertise in the areas of protein production and analytics, drug formulation, clinical development, and regulation.
Beside the classical biotechnology area and biosimilars, Cornelius is working in the area of Advanced Therapy Medicinal Products (ATMP) and medical devices. Using his market experience he is also developing reimbursement strategies for medical devices.
Dr. Peter-Michael Roettger
Peter Michael Roettger as a pharmacist has many years of experience in the management of companies and projects in the pharmaceutical sector, the diagnostic and medical device industry. He is a member of the German Dermatological Society (DDG), the German and European Diabetes Society (EASD). Furthermore, his expertise in this sector has been underlined through his appointment as Curator of the German Diabetes Foundation (DDS). His understanding of important medical and scientific contexts, coupled with market-strategic know-how make Peter the ideal technically experienced consultant in the field of life science.